rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157's Stomach Protection Lasts Long After the Drug Is Gone

RPEP-005591999Sikiric, P; Jadrijevic, S; Seiwerth, S; Sosa, T; Deskovic, S; Perovic, D; Aralica, G; Grabarevic, Z; Rucman, R; Petek, M; Jagic, V; Turkovic, B; Ziger, T; Rotkvic, I; Mise, S; Zoricic, I; Sebecic, B; Patrlj, L; Kocman, B; Sarlija, M; Mikus, D; Separovic, J; Hanzevacki, M; Gjurasin, M; Miklic, P
Animal StudyPreliminary evidence
The takeaway

BPC-157's cytoprotective effect in the gut persists for days after administration, outperforming ranitidine and sucralfate in duration of protection against reflux esophagitis.

Days-long protection

BPC-157's cytoprotective effect persisted for days after administration, far exceeding the duration of ranitidine or sucralfate protection

What the researchers found

BPC-157 provided long-lasting cytoprotection lasting days after administration in gastrectomized rats with duodenal ulcers and reflux esophagitis, significantly outlasting ranitidine and sucralfate.

Why it matters

A drug whose protection outlasts its presence in the body suggests it activates lasting cellular repair programs. This is fundamentally different from acid blockers that only work while present.

How the study worked

Animal study in gastrectomized rats challenged with cysteamine. BPC-157, ranitidine, sucralfate, and cholestyramine were administered, and protection was assessed at multiple timepoints to evaluate duration.

What this study cannot tell us

Animal model in gastrectomized rats, which is specialized. The specific cellular programs activated for lasting protection were not identified.

How to read the evidence

Preliminary animal evidence with innovative experimental design testing duration of protection, providing unique mechanistic insight.

When this study was published

Published in 1999. The concept of BPC-157's lasting cytoprotection has influenced subsequent dosing research.

The bigger picture

The concept of long-lasting cytoprotection suggests BPC-157 reprograms cellular defense mechanisms. If it can induce sustained protection, dosing frequency could be much lower than conventional drugs.

Questions still open

  • What cellular mechanisms does BPC-157 activate for lasting protection?
  • How does this lasting effect inform optimal human dosing schedules?
  • Does the long-lasting protection apply to other tissue types beyond gut?

Common questions

How long does BPC-157's protection last?
In this study, a single dose protected the gut for days afterward — much longer than the peptide itself would be present in the body. This suggests it triggers lasting repair mechanisms rather than just temporarily coating the stomach.
Does this mean you don't need to take it every day?
This animal study suggests BPC-157's effects persist well beyond its presence. If confirmed in humans, it could potentially be taken less frequently than conventional gut medications.

Read the original research

Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.

Journal of physiology, Paris, 93(6), 467-77

View on PubMed ↗

Citation

Sikiric, P; Jadrijevic, S; Seiwerth, S; Sosa, T; Deskovic, S; Perovic, D; Aralica, G; Grabarevic, Z; Rucman, R; Petek, M; Jagic, V; Turkovic, B; Ziger, T; Rotkvic, I; Mise, S; Zoricic, I; Sebecic, B; Patrlj, L; Kocman, B; Sarlija, M; Mikus, D; Separovic, J; Hanzevacki, M; Gjurasin, M; Miklic, P. (1999). Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.. Journal of physiology, Paris, 93(6), 467-77.